140 related articles for article (PubMed ID: 18268067)
1. Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
Hohberg C; Forst T; Larbig M; Safinowski M; Diessel S; Hehenwarter S; Weber MM; Schöndorf T; Pfützner A
Diabetes Care; 2008 May; 31(5):1021-5. PubMed ID: 18268067
[TBL] [Abstract][Full Text] [Related]
2. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
Forst T; Forst S; Strunk K; Löbig M; Welter K; Kazda C; Pfützner A
J Diabetes Complications; 2005; 19(3):128-32. PubMed ID: 15866056
[TBL] [Abstract][Full Text] [Related]
3. Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.
Forst T; Lübben G; Hohberg C; Kann P; Sachara C; Gottschall V; Friedrich C; Rosskopf R; Pfützner A
Microcirculation; 2005; 12(7):543-50. PubMed ID: 16207627
[TBL] [Abstract][Full Text] [Related]
4. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
[TBL] [Abstract][Full Text] [Related]
5. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
Rave K; Klein O; Frick AD; Becker RH
Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
[TBL] [Abstract][Full Text] [Related]
6. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
[TBL] [Abstract][Full Text] [Related]
7. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
[TBL] [Abstract][Full Text] [Related]
8. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
9. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
Schmoelzer I; de Campo A; Pressl H; Stelzl H; Dittrich P; Oettl K; Wascher TC
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):176-81. PubMed ID: 15789278
[TBL] [Abstract][Full Text] [Related]
10. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822
[TBL] [Abstract][Full Text] [Related]
11. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
13. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
14. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
[TBL] [Abstract][Full Text] [Related]
15. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
16. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
17. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
18. Obesity is associated with impaired endothelial function in the postprandial state.
Jonk AM; Houben AJ; Schaper NC; de Leeuw PW; Serné EH; Smulders YM; Stehouwer CD
Microvasc Res; 2011 Nov; 82(3):423-9. PubMed ID: 21875604
[TBL] [Abstract][Full Text] [Related]
19. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
Horvath K; Bock G; Regittnig W; Bodenlenz M; Wutte A; Plank J; Magnes C; Sinner F; Fürst-Recktenwald S; Theobald K; Pieber TR
Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
[TBL] [Abstract][Full Text] [Related]
20. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
